News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,267 Results
Type
Article (14031)
Company Profile (106)
Press Release (257130)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (89289)
Career Advice (515)
Deals (15620)
Drug Delivery (67)
Drug Development (37037)
Employer Resources (54)
FDA (6527)
Job Trends (6356)
News (152486)
Policy (14246)
Tag
Academia (485)
Accelerated approval (2)
Adcomms (6)
Allergies (36)
Alliances (23577)
ALS (39)
Alzheimer's disease (397)
Antibody-drug conjugate (ADC) (47)
Approvals (6568)
Artificial intelligence (114)
Autoimmune disease (9)
Automation (5)
Bankruptcy (150)
Best Places to Work (4521)
BIOSECURE Act (9)
Biosimilars (59)
Biotechnology (44)
Bladder cancer (24)
Brain cancer (16)
Breast cancer (83)
Cancer (666)
Cardiovascular disease (76)
Career advice (455)
Career pathing (14)
CAR-T (24)
Cell therapy (93)
Cervical cancer (4)
Clinical research (31318)
Collaboration (368)
Compensation (171)
Complete response letters (17)
COVID-19 (766)
CRISPR (23)
C-suite (137)
Cystic fibrosis (39)
Data (714)
Denatured (15)
Depression (11)
Diabetes (87)
Diagnostics (1398)
Diversity (2)
Diversity, equity & inclusion (16)
Drug discovery (61)
Drug pricing (67)
Drug shortages (12)
Duchenne muscular dystrophy (39)
Earnings (32818)
Editorial (12)
Employer branding (5)
Employer resources (48)
Events (38487)
Executive appointments (411)
FDA (7015)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (228)
Gene editing (41)
Generative AI (9)
Gene therapy (108)
GLP-1 (356)
Government (1335)
Grass and pollen (3)
Guidances (46)
Healthcare (3796)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (803)
Inflammatory bowel disease (59)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (61)
IPO (6059)
IRA (29)
Job creations (2066)
Job search strategy (414)
Kidney cancer (6)
Labor market (13)
Layoffs (182)
Leadership (5)
Legal (3453)
Liver cancer (19)
Lung cancer (94)
Lymphoma (59)
Machine learning (3)
Management (17)
Manufacturing (170)
MASH (34)
Medical device (1492)
Medtech (1495)
Mergers & acquisitions (9787)
Metabolic disorders (275)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (26)
Neuropsychiatric disorders (9)
Neuroscience (594)
NextGen: Class of 2025 (1651)
Non-profit (657)
Now hiring (8)
Obesity (156)
Opinion (125)
Ovarian cancer (22)
Pain (57)
Pancreatic cancer (17)
Parkinson's disease (48)
Partnered (9)
Patents (125)
Patient recruitment (33)
Peanut (10)
People (29305)
Pharmaceutical (65)
Pharmacy benefit managers (12)
Phase I (8195)
Phase II (13248)
Phase III (11863)
Pipeline (516)
Policy (73)
Postmarket research (1410)
Preclinical (3287)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (173)
Real estate (2661)
Recruiting (18)
Regulatory (10320)
Reports (14)
Research institute (585)
Resumes & cover letters (58)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (39)
Series A (38)
Series B (18)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (7)
Startups (1654)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (35)
The Weekly (30)
Vaccines (159)
Venture capitalists (14)
Weight loss (103)
Women's health (8)
Worklife (5)
Date
Today (112)
Last 7 days (323)
Last 30 days (1033)
Last 365 days (12025)
2025 (4249)
2024 (12839)
2023 (14609)
2022 (20050)
2021 (20600)
2020 (19533)
2019 (15346)
2018 (12040)
2017 (14120)
2016 (13303)
2015 (15736)
2014 (12620)
2013 (10743)
2012 (11574)
2011 (12113)
2010 (10996)
Location
Africa (322)
Alabama (13)
Alaska (1)
Arizona (58)
Arkansas (3)
Asia (20468)
Australia (2647)
California (1924)
Canada (956)
China (255)
Colorado (74)
Connecticut (72)
Delaware (66)
Europe (40304)
Florida (352)
Georgia (40)
Idaho (9)
Illinois (218)
India (16)
Indiana (139)
Iowa (1)
Japan (99)
Kansas (59)
Kentucky (13)
Louisiana (2)
Maine (3)
Maryland (272)
Massachusetts (1614)
Michigan (31)
Minnesota (109)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (10)
New Hampshire (7)
New Jersey (816)
New Mexico (7)
New York (564)
North Carolina (411)
North Dakota (2)
Northern California (814)
Ohio (53)
Oklahoma (4)
Oregon (16)
Pennsylvania (473)
Puerto Rico (11)
Rhode Island (10)
South America (516)
South Carolina (4)
Southern California (778)
Tennessee (35)
Texas (247)
United States (7853)
Utah (37)
Virginia (80)
Washington D.C. (32)
Washington State (131)
Wisconsin (21)
271,267 Results for "aspire pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AviadoBio Announces Completion of Second Cohort in Phase 1/2 ASPIRE-FTD Clinical Trial Studying AVB-101 for FTD-GRN
May 1, 2025
·
4 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
·
3 min read
Press Releases
BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029
March 20, 2025
·
5 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
February 20, 2025
·
5 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.
July 1, 2024
·
7 min read
Lymphoma
Regeneron Narrows Approval Aspirations for Lymphoma Bispecific, Citing ‘Competitor Developments’
The company will push through with an accelerated approval application for odronextamab in follicular lymphoma, leaving diffuse large B cell lymphoma behind.
February 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Imperative Care Launches its Next Innovation to Elevate Ischemic Stroke Treatment and Announces First Patients Treated with Continuous Dual Aspiration Technique
May 7, 2025
·
4 min read
Press Releases
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
March 20, 2025
·
5 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
February 26, 2025
·
6 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 30, 2025
·
5 min read
1 of 27,127
Next
